Systems biology approach to identify alterations in the stem cell reservoir of subcutaneous adipose tissue in a rat model of diabetes: effects on differentiation potential and function

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Diabetologia

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00125-013-3081-zPMID 24132782
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adipose-Derived Stem Cells as a Novel Tool for Future Regenerative Medicine

  2014cited by this paper
• REGENERATIVE MEDICINE Concise Review: Adipose-Derived Stem Cells as a Novel Tool for Future Regenerative Medicine

  2012cited by this paper
• Preadipocytes of type 2 diabetes subjects display an intrinsic gene expression profile of decreased differentiation capacity

  2011cited by this paper
• Role of WNT signalling in the determination of human mesenchymal stem cells into preadipocytes.

  2011cited by this paper
• Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells.

  2010cited by this paper
• Wnt pathway antagonists and angiogenesis

  2010cited by this paper
• The role of FGF/Erk signaling in pluripotent cells

  2010cited by this paper
• γ‐secretase inhibitor induces adipogenesis of adipose‐derived stem cells by regulation of Notch and PPAR‐γ

  2010cited by this paper
• Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells

  2010cited by this paper
• The Role of Wnt Signaling in Physiological and Pathological Angiogenesis

  2010cited by this paper
• Leptin Functions Peripherally to Regulate Differentiation of Mesenchymal Progenitor Cells

  2010cited by this paper
• The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis.

  2009cited by this paper
• Notch signaling enhances osteogenic differentiation while inhibiting adipogenesis in primary human bone marrow stromal cells.

  2009cited by this paper
• Angiogenesis: a team effort coordinated by notch.

  2009cited by this paper
• Adipose tissue-derived stem cells: characterization and potential for cardiovascular repair.

  2009cited by this paper
• Embryonic Stem Cell Marker Expression Pattern in Human Mesenchymal Stem Cells Derived from Bone Marrow, Adipose Tissue, Heart and Dermis

  2009cited by this paper
• Comparison of Different Adult Stem Cell Types for Treatment of Myocardial Ischemia

  2008cited by this paper
• Wnt/Frizzled signaling in angiogenesis

  2008cited by this paper
• Reprogramming of human somatic cells to pluripotency with defined factors

  2008cited by this paper
• High glucose induces adipogenic differentiation of muscle-derived stem cells

  2008cited by this paper
• Adipose-derived stem cell: A better stem cell than BMSC

  2008cited by this paper
• Adipose-derived stem cells for regenerative medicine.

  2007cited by this paper
• Notch Ligand Delta-Like 1 Is Essential for Postnatal Arteriogenesis

  2007cited by this paper
• Effects of high glucose on mesenchymal stem cell proliferation and differentiation.

  2007cited by this paper
• How stem cells age and why this makes us grow old

  2007cited by this paper
• Concise Review: Adipose Tissue‐Derived Stromal Cells—Basic and Clinical Implications for Novel Cell‐Based Therapies

  2007cited by this paper
• Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing

  2007cited by this paper
• Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

  2006cited by this paper
• Mesenchymal stem cells reside in virtually all post-natal organs and tissues

  2006cited by this paper
• Impaired potency of bone marrow mononuclear cells for inducing therapeutic angiogenesis in obese diabetic rats.

  2006cited by this paper
• Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages.

  2006cited by this paper
• Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia–reperfusion injury in rats

  2006cited by this paper
• Autocrine Fibroblast Growth Factor 2 Signaling Is Critical for Self‐Renewal of Human Multipotent Adipose‐Derived Stem Cells

  2006cited by this paper
• Clinical trials update from the American Heart Association: REPAIR‐AMI, ASTAMI, JELIS, MEGA, REVIVE‐II, SURVIVE, and PROACTIVE

  2006cited by this paper
• Disparate Mesenchyme‐Lineage Tendencies in Mesenchymal Stem Cells from Human Bone Marrow and Umbilical Cord Blood

  2006cited by this paper
• Advanced Glycation End‐Products Attenuate Human Mesenchymal Stem Cells and Prevent Cognate Differentiation Into Adipose Tissue, Cartilage, and Bone

  2005cited by this paper
• Developmental cell biology: Regulatory networks in embryo-derived pluripotent stem cells

  2005cited by this paper
• Mesenchymal stem cells and their potential as cardiac therapeutics.

  2004cited by this paper
• Notch pathway is dispensable for adipocyte specification

  2004cited by this paper
• Novel angiogenic signaling pathways and vascular targets.

  2004cited by this paper
• The role of Notch in tumorigenesis: oncogene or tumour suppressor?

  2003cited by this paper
• Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures

  2002cited by this paper
• Human adipose tissue is a source of multipotent stem cells.

  2002cited by this paper
• Bone marrow cells regenerate infarcted myocardium

  2001cited by this paper
• Validation of Endogenous Controls for Gene Expression Studies in Human Adipocytes and Preadipocytes

  2001cited by this paper
• Implantation of Bone Marrow Mononuclear Cells Into Ischemic Myocardium Enhances Collateral Perfusion and Regional Function via Side Supply of Angioblasts, Angiogenic Ligands, and Cytokines

  2001cited by this paper
• Experimental NIDDM: Development of a New Model in Adult Rats Administered Streptozotocin and Nicotinamide

  1998cited by this paper
• Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4.

  1998cited by this paper
• Notch-1 Controls the Expression of Fatty Acid-activated Transcription Factors and Is Required for Adipogenesis*

  1997cited by this paper
• The Diabetic Zucker Fatty Rat

  1983cited by this paper
• Osteogenesis in transplants of bone marrow cells.

  1966cited by this paper

• bFGF rescues dysfunctional properties of adipose-derived stem cells from individuals with type 2 diabetes by modulating their miRNA profile

  2025cites this paper
• White adipose tissue in type 2 diabetes and the effect of antidiabetic drugs

  2025cites this paper
• The effect of diabetes mellitus on differentiation of mesenchymal stem cells into insulin-producing cells

  2024cites this paper
• Mesenchymal Stem Cell Therapy- A Promising Treatment for Wound Healing in Diabetic Patients

  2024cites this paper
• Diabetic microenvironment deteriorates the regenerative capacities of adipose mesenchymal stromal cells

  2024cites this paper
• Considerations for enhanced mesenchymal stromal/stem cell myogenic commitment in vitro

  2023cites this paper
• Wharton’s jelly mesenchymal stem cells transplantation for critical limb ischemia in patients with type 2 diabetes mellitus: a preliminary report of phase I clinical trial

  2023cites this paper
• Adipose-Derived Stem Cells to Treat Ischemic Diseases: The Case of Peripheral Artery Disease

  2023cites this paper
• An Update on Adipose‐Derived Stem Cells for Regenerative Medicine: Where Challenge Meets Opportunity

  2023cites this paper
• dCas9-Based PDGFR–β Activation ADSCs Accelerate Wound Healing in Diabetic Mice through Angiogenesis and ECM Remodeling

  2023cites this paper
• Perivascular and epicardial adipose tissue.

  2023cites this paper
• Type 2 Diabetes Mellitus Facilitates Shift of Adipose-Derived Stem Cells Ex Vivo Differentiation toward Osteogenesis among Patients with Obesity

  2022cites this paper
• Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia

  2022cites this paper
• Urethral injection of dedifferentiated fat cells ameliorates sphincter damage and voiding dysfunction in a rat model of persistence stress urinary incontinence

  2022cites this paper
• Subcutaneous Adipose Stem Cells in Obesity: The Impact of Bariatric Surgery

  2021cites this paper
• Impaired Proliferation, Apoptosis, and Angiogenesis of Adipose-Derived Stem Cells Isolated from Rats during the Course of Diabetes

  2021cites this paper
• Influence of the patient’s somatic factors on the properties of lipoaspirate

  2021cites this paper
• Impact of Diabetes Mellitus on the Potential of Autologous Stem Cells and Stem Cell–Derived Microvesicles to Repair the Ischemic Heart

  2021cites this paper
• Role of Hyperglycemia in the Senescence of Mesenchymal Stem Cells

  2021cites this paper
• Cardiovascular Risk Factors and Differential Transcriptomic Profile of the Subcutaneous and Visceral Adipose Tissue and Their Resident Stem Cells

  2020cites this paper
• Adipose-derived stem cells combined with platelet-rich plasma enhance wound healing in a rat model of full-thickness skin defects

  2020cites this paper
• Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease: A Review of the Studies Using Syngeneic, Autologous, Allogeneic, and Xenogeneic Cells

  2020cites this paper
• The Effect of Autologous Dedifferentiated Fat Cell Transplantation in a Pig Model of Hindlimb Ischemia

  2020cites this paper
• Prolonged Therapeutic Effects of Photoactivated Adipose-derived Stem Cells following Ischemic Injury.

  2020cites this paper
• Pretreatment of Diabetic Adipose-derived Stem Cells with mitoTEMPO Reverses their Defective Proangiogenic Function in Diabetic Mice with Critical Limb Ischemia

  2019cites this paper
• Adipose tissue, angiogenesis and angio-MIR under physiological and pathological conditions.

  2019cites this paper
• Adipose-derived stromal/stem cells from different adipose depots in obesity development

  2019cites this paper
• Adipose-Derived Mesenchymal Stem Cells Isolated from Patients with Type 2 Diabetes Show Reduced “Stemness” through an Altered Secretome Profile, Impaired Anti-Oxidative Protection, and Mitochondrial Dynamics Deterioration

  2019cites this paper
• Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus

  2019cites this paper
• Metabolic reprogramming in atherosclerosis: Opposed interplay between the canonical WNT/β-catenin pathway and PPARγ.

  2019cites this paper
• Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs

  2019cites this paper
• Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway

  2019cites this paper
• Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes

  2019cites this paper
• Impaired immunomodulatory ability of type 2 diabetic adipose-derived mesenchymal stem cells in regulation of inflammatory condition in mixed leukocyte reaction

  2019cites this paper
• Stem cells from human cardiac adipose tissue depots show different gene expression and functional capacities

  2019cites this paper
• PDGF Restores the Defective Phenotype of Adipose-Derived Mesenchymal Stromal Cells from Diabetic Patients.

  2018cites this paper
• The use of fat grafting and platelet‐rich plasma for wound healing: A review of the current evidence

  2018cites this paper
• Towards adipose tissue-derived stromal cells-based therapy for diabetic retinopathy

  2018cites this paper
• Adipocyte biology: It is time to upgrade to a new model

  2018cites this paper
• Tissue Engineering and Regenerative Medicine Glyoxalase-1 Overexpression Reverses Defective Proangiogenic Function of Diabetic Adipose-Derived Stem Cells in Streptozotocin-Induced Diabetic Mice Model of Critical Limb Ischemia

  2017cites this paper
• mCRP triggers angiogenesis by inducing F3 transcription and TF signaling in microvascular endothelial cells Running title: CRP isoforms and angiogenesis

  2017cites this paper
• Position paper of the European Society of Cardiology-working group of coronary pathophysiology and microcirculation: obesity and heart disease.

  2017cites this paper
• CD146+ skeletal stem cells from growth plate exhibit specific chondrogenic differentiation capacity in vitro

  2017cites this paper
• Allogenic adipose-derived stem cell therapy overcomes ischemia-induced microvessel rarefaction in the myocardium: systems biology study

  2017cites this paper
• The endothelial cell secretome as a novel treatment to prime adipose‐derived stem cells for improved wound healing in diabetes

  2017cites this paper
• Effects of maternal obesity on Wharton’s Jelly mesenchymal stromal cells

  2017cites this paper
• Adipose tissue depots and inflammation: effects on plasticity and resident mesenchymal stem cell function.

  2017cites this paper
• Assessment of Energy Metabolic Changes in Adipose Tissue-Derived Stem Cells.

  2017cites this paper
• Wnt signaling in the vessel wall

  2017cites this paper
• Systematic review of patient factors affecting adipose stem cell viability and function: implications for regenerative therapy

  2017cites this paper
• Diet-induced obesity regulates adipose-resident stromal cell quantity and extracellular matrix gene expression.

  2016influential citation
• Obesity‐driven alterations in adipose‐derived stem cells are partially restored by weight loss

  2016cites this paper
• mCRP triggers angiogenesis by inducing F3 transcription and TF signalling in microvascular endothelial cells

  2016cites this paper
• Inhibition of Notch rescues the angiogenic potential impaired by cardiovascular risk factors in epicardial adipose stem cells

  2016cites this paper
• Gene and Cell Therapy in Heart Failure

  2016cites this paper
• The impact of diet-induced obesity and exercise on adipose-resident stem cells

  2016influential citation
• Effects of Streptozotocin-Induced Diabetes on Proliferation and Differentiation Abilities of Mesenchymal Stem Cells Derived from Subcutaneous and Visceral Adipose Tissues.

  2016cites this paper
• Airway remodeling: Systems biology approach, from bench to bedside

  2016cites this paper
• Adipose-derived Mesenchymal Stem Cells and Their Reparative Potential in Ischemic Heart Disease.

  2015cites this paper
• Altered Metabolic and Stemness Capacity of Adipose Tissue-Derived Stem Cells from Obese Mouse and Human

  2015cites this paper
• Adipose tissue-derived mesenchymal stem cells and platelet-rich plasma: stem cell transplantation methods that enhance stemness

  2015cites this paper
• Effects of autologous adipose-derived stem cell infusion on type 2 diabetic rats.

  2015cites this paper
• Effect of Diabetes Mellitus on Adipocyte‐Derived Stem Cells in Rat

  2015cites this paper
• Differences in the Osteogenic Differentiation Capacity of Omental Adipose-Derived Stem Cells in Obese Patients With and Without Metabolic Syndrome.

  2015cites this paper
• Células madre mesenquimales derivadas de tejido adiposo y su potencial reparador en la enfermedad isquémica coronaria

  2015cites this paper
• Experimental cell therapy: the search for the best stem cell continues.

  2014cites this paper
• Characterization of human adipose tissue‐derived stromal cells isolated from diabetic patient's distal limbs with critical ischemia

  2014cites this paper
• Technology Advancement for Integrative Stem Cell Analyses

  2014cites this paper
• Notch Signaling Pathway Activation in Normal and Hyperglycemic Rats Differs in the Stem Cells of Visceral and Subcutaneous Adipose Tissue

  2014cites this paper
• Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus

  2014cites this paper
• Cost-Effective, Safe, and Personalized Cell Therapy for Critical Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus Limb Ischemia in Type 2 Diabetes Mellitus

  year unknowncites this paper